Cocrystal Discovery, Inc. is a privately funded biotechnology company developing antiviral therapeutics for human diseases.  Cocrystal has breakthrough technologies that enable the creation of first- and best-in-class antivirals.  Our mission today is to discover and develop small molecule inhibitors of the viral replication complex.  

Viral diseases represent one of the world’s largest and greatest unmet medical needs.  We are currently focusing on:
    -Hepatitis C virus
    -Influenza virus
    -Rhinovirus (common cold)